Executive Summary

In recent years the emergence of powerful Large Language Models (LLMs) – notably OpenAI’s ChatGPT series and Anthropic’s Claude – has revolutionized how biotechnology research and industry operate. These conversational AI systems, when guided by effective prompt strategies, can assist with tasks ranging from literature summarization to experiment design, compound discovery, and regulatory document drafting. We conducted a thorough analysis of 2026-era capabilities and “prompt engineering” approaches for ChatGPT and Claude in biotech applications. Drawing on published literature, industry reports, and case studies, we find that structured, context-rich prompts (e.g. role-based instructions and chain-of-thought cues) significantly improve AI performance on technical biology tasks. For example, explicitly instructing the model to “think step by step” can greatly enhance reasoning accuracy (^[1]), while specifying the assistant’s persona (e.g. “You are an expert molecular biologist”) helps steer outputs toward domain-specific style and content (^[2]) (^[1]). By 2026, both ChatGPT and Claude offer extended context windows (hundreds of thousands of tokens or more (^[3]) (^[4])), integration with domain databases, and fine-grained control options. However, differences remain: Claude emphasizes a “privacy-first” infrastructure and “constitutional AI” safety, appealing to regulated biotech sectors (^[5]) (^[6]), whereas ChatGPT’s broader ecosystem (plugins, code interpreter, etc.) provides diverse tool integrations. Our report outlines best practices for prompt design (including zero-shot, few-shot, CoT, and iterative techniques), compares platform capabilities, and presents numerous biotech-themed prompt examples (see Tables 1–2). We also analyze empirical findings on LLM accuracy in biomedical contexts (^[7]) (^[8]), discuss real-world deployments (from AstraZeneca’s “AZ-ChatGPT” agent to Claude’s healthcare suite (^[9]) (^[10])), and explore future directions. In conclusion, carefully crafted prompting – backed by expert guidance and oversight – is essential to harness generative AI safely and effectively in biotechnology, and will shape research productivity and innovation in the coming years.

Introduction and Background

The intersection of generative AI and biotechnology has rapidly become transformative. Landmark developments – from the sequencing of millions of genomes to the AlphaFold-driven revelation of protein structures – are now being “turbocharged by AI” (^[11]). As former President Barack Obama’s National Security Commission noted in 2024, biological innovation is entering a phase analogous to the original “digital revolution,” potentially allowing us to “program biology just as we program computers” (^[11]). OpenAI’s ChatGPT (launched 2022) and Anthropic’s Claude (launched 2023) are two leading platforms in this space. These LLM-powered assistants have quickly moved from novelty to enterprise priority in life sciences: one industry survey found that within two years of ChatGPT’s introduction, cancer drugmakers and biotech firms were piloting or deploying generative AI internally (^[12]) (^[6]).

Academic and industry analyses forecast enormous productivity gains from this trend. A McKinsey report (2024) projects that AI in pharma could unlock $60–110 billion per year by accelerating drug discovery and development (^[13]). In drug R&D specifically, generative AI is already credited with “accelerat [ing] drug discovery, improv [ing] targets, and boost [ing] R&D productivity” (^[14]). Startups like EvolutionaryScale have even built language-model-based tools (e.g. “ESM3”) that design novel protein sequences on demand (^[15]). In clinical settings, ChatGPT and Claude have demonstrated the ability to provide useful diagnostic and therapeutic suggestions, albeit with critical caveats (see later sections) (^[7]) (^[8]). Altogether, these advances suggest biotechnology is approaching a “ChatGPT moment” of its own (^[16]).

However, the promise of LLMs in biotech comes with significant challenges. Biotech data and decisions are highly sensitive, regulated, and technical. In 2024–26 many life-sciences companies initially banned ChatGPT usage over data-leakage and compliance fears (^[17]), even as analysts warned that “AI is being integrated into high-stakes sectors like medicine” more rapidly than debated policy can catch up (^[18]). Moreover, knowledge errors (“ hallucinations”) by LLMs can be dangerous in healthcare contexts (^[19]) (^[20]). This environment places a premium on prompt engineering — the practice of carefully designing inputs so that the model’s output is reliable, relevant, and appropriately detailed. We define prompt strategies broadly to include the structure, phrasing, and contextual framing given to ChatGPT or Claude, including system messages, role instructions, examples, and output constraints.

What has been termed the “art and science” of prompt design (^[2]) has evolved rapidly through intensive community experimentation and published guidance. In this report, we synthesize the state of prompt engineering for ChatGPT and Claude circa 2026, with a special focus on biotech applications. This includes historical context and model capabilities, an in-depth taxonomy of prompting techniques (with examples), empirical evidence on effectiveness, industry use cases, and implications for future practice. All claims are supported by literature and expert commentary.

ChatGPT and Claude: Model Evolution and Capabilities

ChatGPT (OpenAI)

ChatGPT refers to chat-based interfaces built on OpenAI’s GPT-3, GPT-3.5, and GPT-4 families (and beyond).By 2026, OpenAI has iteratively enhanced GPT-4 (e.g. the GPT-4o/Turbo variants) and even announced GPT-4 Turbo with one-million-token contexts (^[4]). At formal release, GPT-4 Turbo supports context windows up to 128k tokens (or 1M in enterprise configurations) as compared to GPT-4’s original 8k (^[4]). This means entire dissertations or large genomic datasets can be fed into one prompt if engineered carefully. The model’s knowledge base extends through at least late 2023 (GPT-4 Turbo’s stated cutoff) and likely includes biomedical literature up to 2023 (OpenAI’s GPT-4o knowledge): indeed BytePlus (2025) reports ChatGPT’s knowledge may be updated through April 2025 (^[21]). In usage, ChatGPT offers advanced features like browsing, code interpreter (for data analysis), and plugins to call external tools or databases.

OpenAI has focused ChatGPT’s capabilities toward versatility and creativity. Even without prompting, GPT-4 effectively performs multi-step reasoning on many tasks. Some researchers note that unlike earlier models, GPT-4 often “already … implicitly” follows chain-of-thought reasoning without explicit instruction (^[22]). However, specialized prompting (see below) still further improves results on difficult tasks (^[1]). ChatGPT’s interface allows a separate system message (set by the developer or user) which can define the assistant’s global persona or rules, and then a user message for the actual question. Fine-tuning and reinforcement learning from human feedback (RLHF) are applied in training to align outputs with user intent. By 2026, OpenAI labels ChatGPT as useful in medical and biotech by subscription (e.g. “ChatGPT Health”), indicating improvements in data privacy and custom compliance features (^[23]).

Claude (Anthropic)

Anthropic’s Claude models (Opus, Sonnet, Haiku variants) are the main alternative to ChatGPT. Claude’s development emphasizes safety, context length, and configurability. As of Claude 4.x (2025–26), the Sonnet and Opus models offer a 200,000-token context window in standard mode, extendable to 500,000 tokens for enterprise users (^[3]). This exceeds early GPT-4 and matches or surpasses most open LLMs. Claude’s knowledge cutoff (likely late 2023 to early 2024) is comparable to GPT-4’s. Importantly, Anthropic markets Claude as “privacy-first” and tension-free with sensitive data: by default Claude does not use user chats for model training, and enterprise data is locked down (^[24]). Anthropic’s “constitutional AI” approach embeds safety rules (e.g. no harmful medical advice) into the model’s policy (^[5]).

Functionally, Claude is delivered either through a chat interface or API, similar to ChatGPT. However, Anthropic provides advanced features like Claude Projects and Skills which let users feed large document collections (e.g. database of research papers) and have Claude fetch relevant info from them. Prompting Claude often follows a recommended 10-component framework (context, task, examples, style, etc.) (^[25]), though the user still inputs text much like ChatGPT. Claude’s strengths have shown up in benchmarks: a 2024 study found Claude 3 Opus outperformed ChatGPT 4.0 on medical diagnosis questions (^[7]), and many early adopters in pharma cite Claude’s built-in compliance as an advantage.

Technical Comparison (2026)

• Note: ChatGPT’s system prompt can be pre-set but is not accessible to end-users in the UI; instead users typically phrase instructions as if telling the role. Claude’s “system prompt” is handled via Anthropic’s recommended framework.

Prompt Engineering Fundamentals

Prompt engineering is the practice of crafting LLM inputs (the “prompts”) so as to maximize the relevance, accuracy, and efficiency of the model’s outputs. The key insight is that modern LLMs perform best when given clear, detailed instructions and context (^[2]). Unlike classical programming, the user does not write code; instead, they “program” the AI by language. As Yinheng Li et al. note, successful prompt-based LLM usage can often be treated as an optimization problem – searching for the “optimal prompt P*” that yields the best answers (^[2]) (^[27]).

Numerous prompting techniques have been documented. Table 1 summarizes foundational strategies. In ChatGPT-style interfaces, one can use role instructions (e.g. “You are a senior data scientist”) and output directives (e.g. “Summarize in 3 bullet points”) (^[28]) (^[28]). Chain-of-thought (CoT) prompting explicitly asks the model to show its reasoning steps (via phrases like “Let’s think step-by-step”) (^[1]) (^[29]). Few-shot prompting presents examples in the prompt to guide the model on complex tasks (e.g. showing one or two solved problems before asking a new one) (^[2]). Constraint-based techniques (e.g. “only output valid chemical names”) shape format and content. And iterative or interactive strategies (“Now correct any errors in your reasoning”) refine answers after an initial response.

Prompts for Claude share the same high-level ideas but often use Anthropic’s formal “10-component” structure (^[30]) (^[25]). Anthropic advises including components like explicit instructions, relevant context science information, example inputs/outputs, desired style and output format, and safeguards against errors. For instance, one might begin a Claude prompt with: “Role: [Scientist]; Context: [biotech project]; Task: [summarize findings and cite sources]; Constraints: [no hallucinations].” By contrast, in ChatGPT the user would typically embed much of this in a single user message (or a system message if available).

Regardless of platform, general principles apply: be explicit and precise, provide relevant context, and control output format. As one survey emphasizes, the “key to success lies in effective prompt design” – there is no one-size-fits-all solution, and prompts must often be tuned and evaluated (^[2]) (^[31]). In practice this means:

• Contextualization: Prepend or follow prompts with background (e.g. “In a study on E. coli metabolism…”), so the model draws on the right aspect of its knowledge.
• Role specification: Explicitly name the assistant’s persona (e.g. “You are an immunologist” or “Expert lab scientist specializing in protein biochemistry” (^[28])). This biases style and vocabulary.
• Chain-of-Thought triggers: Instruct the AI to reason step-by-step for complex analytical tasks (^[1]).
• Few-shot examples: Provide one or more illustrative examples of the desired Q&A format (especially useful for tasks like data extraction or classification).
• Output formatting: Request structured outputs (bullet lists, tables, code snippets) to make interpretations easier.
• Error-checking instructions: Prompt the model to verify or fact-check its own answer (e.g. “After answering, double-check for mistakes”).
• Iteration and Multi-turn: If the first answer is incomplete, requery with clarification or constraint adjustments.

These methods (and many hybrids) are extensively used; see Table 1 for sample prompts illustrating key strategies. Effective prompts often combine multiple techniques (e.g. role + CoT + bullet formatting) to coax the best responses (^[29]) (^[32]).

Table 1: Illustrative prompt templates using ChatGPT and Claude for biotech tasks. Each prompt incorporates one or more engineering principles (role assignment, chain-of-thought guidance, few-shot exemplars, etc.) to clarify expectations and structure outputs (^[1]) (^[29]).

ChatGPT vs. Claude: Prompt Strategy Comparisons

While many prompting principles overlap between ChatGPT and Claude, certain platform-specific considerations arise:

• System Prompts and Persona: ChatGPT’s chat interface allows a system message (set by the developer) that can define the assistant’s identity and rules. Users exploit this indirectly by phrasing prompts in the first person (e.g. “You are Dr. X, do Y”). In Claude’s interface, all instructions are in a single user step but often segmented by Anthropic’s suggested structure (see Table 1). In both cases, explicitly establishing the assistant’s domain expertise (e.g. as a “biostatistician”) guides style and reduces generative ambiguity.

• Length and Context Management: Claude’s very large context windows (200k+ tokens (^[3])) allow feeding entire research articles or genomic datasets, whereas ChatGPT’s practical context limit (128k tokens for Turbo) though high, is smaller (^[4]). For extremely long documents, users of either system must employ strategies: chunking input, iterative summaries, or retrieval mechanisms. Anthropic’s “Projects” feature can load multi-document corpora and retrieve relevant snippets up to the token limit (^[33]). ChatGPT users often use retrieval-augmented generation (RAG) via plugins or embeddings to similar effect. Prompt tactics like progressive summarization (“summarize these 5000 words, then answer X”) are common in both systems.

• Reasoning and Chain-of-Thought: As noted, GPT-4 now often performs internal reasoning without explicit cues (^[22]), but adding phrases like “Let’s think it through step by step” frequently enhances outcome, especially for multi-step biotech problems (e.g. calculating molarity, multi-gene interactions) (^[1]). Claude similarly benefits from asking for reasoning or using its built-in chain-of-thought capabilities (which can be invoked by prompts like “Reasoning:” followed by explanation). Importantly, if a task involves strict logic (e.g. pathway analysis, mathematical models), we found that explicitly requesting bullet lists or numbered logic paths helps prevent hallucination (^[29]) (^[19]).

• Few-Shot and Examples: To teach format or precision (e.g. how to list genetic variants, or write bioinformatics queries), it is effective to give 2–5 worked examples in the prompt. For instance, embedding one example of summarizing a paper into a prompt signals the style for ChatGPT (^[31]). Claude’s multi-turn memory can use earlier messages as implicit examples. In biotech use-cases such as data annotation or literature curation, engineers often supply annotated lines or JSON examples within the prompt to ground the response.

• Output Control: In biotechnology, precise output structure is often needed (e.g. a list of gene primers, a FASTA sequence, a table of experiment parameters). Both ChatGPT and Claude respect explicit format instructions. For example, one may say “Return an answer as valid JSON with keys ‘gene’, ‘value’” or “Present a table with columns X, Y, Z”. Claude even supports XML-like tags and custom formats more robustly, as noted in Anthropic’s guide (^[34]). Specifying constraints (e.g. “only use evidence from provided passages”) is crucial to reduce unsupported claims.

• Multi-Turn and Tool Use: A final strategy is chaining prompts across multiple steps. For instance, one might first ask the LLM to outline an experiment, then in a follow-up chat refine each bullet, then ask for references. ChatGPT’s toolset (Plugins, Code Interpreter) can complement this: e.g., one can prompt ChatGPT to use a genomic database API within the conversation. Claude offers “Skills” and external tool calls via its Claude Code CLI. In practice, biotech prompt engineers often split workflows into prompt chains (vector knowledge retrieval → answer generation → verification) across systems.

In sum, both platforms demand clarity, domain framing, and iterative refinement in prompts. Figures from recent research underscore that prompt quality dramatically affects outcomes: even highly qualified LLMs can falter on biomedical tasks if given vague instructions. For example, a 2024 comparison across health scenarios reported that simpler prompts yielded weak answers (median score 1/5 on antimicrobial-use queries), while more structured prompting improved accuracy (^[8]) (^[35]). In contrast, prompts that exploit the models’ strengths (role-playing, context, reasoning) resulted in much better performance (^[1]) (^[10]).

Biotech Use Cases and Prompt Examples

Below we examine several concrete biotech tasks and illustrate how ChatGPT and Claude can be prompted to tackle them. These examples synthesize expert advice with actual case studies, and include model inputs that emphasize effective strategies. Many example prompts are shown in Table 2 and described in the text.

1. Literature Review and Summarization

Task: Given a research article or abstract, extract key findings, methods, and implications.

• ChatGPT Prompt Example:

“You are a senior molecular biologist teaching graduate students. Here is the abstract of a study on CRISPR gene editing of cancer cells. Please summarize the objectives, key methods, and findings in five bullet points, using clear technical language and citing any result with its figure number if available.”

This prompt combines a role (“senior molecular biologist”), a task (“summarize… in bullet points”), and a constraint (exact number of points). It encourages structured output and relevant detail. It also guides style (graduate-level clarity) and content (mention figure citations).

• Claude Prompt Example:

“Role: Lead geneticist. Context: Abstract about CRISPR editing in oncology studies. Task: Summarize the study’s purpose, methodology, and outcomes. Output as a numbered list of five points. Include specific gene names and experimental details.”

Claude’s prompt similarly sets a role and breaks the answer into a list. The emphasis on precise details (“gene names,” “experimental details”) exemplifies giving domain-specific cues in the prompt.

Techniques Used: Role assignment, output formatting, explicit detail pointers. The chain-of-thought is invoked by expecting separate bullet steps, which helps ensure each point is distinct. A follow-up prompt might refine the summary or ask clarifying questions.

2. Experimental Design

Task: Propose a laboratory experiment given a research question.

• ChatGPT Prompt:

“You are a research scientist in microbial biotechnology. Design an experiment to test how pH levels affect E. coli growth rate. Specify the hypotheses, control and variable groups, measurement plan, and expected results.”

This prompt is multi-part: it requests hypotheses, groups, methods, and predictions. By using the role of “research scientist,” the prompt signals to use professional terminology.

• Claude Prompt:

“Role: Bioindustrial engineer. Context: Investigating pH effect on bacterial growth. Task: Outline a lab experiment step-by-step. Include hypothesis, independent/dependent variables, control setup, and data collection methods. Present answer in numbered steps.”

The Claude version explicitly says “step-by-step” and to use numbering, which structures the response. Asking for specific elements (variables, setup) forces the model to cover all aspects, reducing omissions.

Techniques: In both prompts, we used explicit directive for experiment components. The output is constrained to a stepwise plan, leveraging chain-of-thought implicitly. In practice, the user might further scaffold by follow-up prompts (e.g. “Now list possible sources of error”).

3. Biotech Data Analysis (e.g., Sequence Informatics)

Task: Analyze or transform biological sequence data or related measurements.

• ChatGPT Prompt:

“You are a bioinformatician. Here is a DNA sequence: ATGCTAGCTGA.... Identify all open reading frames (ORFs) longer than 100 bp and translate them to amino acid sequences.”

This direct prompt asks for sequence analysis. ChatGPT may attempt to process the sequence textually. For large sequences, one might instead use a plugin or code interpreter.

• Claude Prompt:

“Task: Translate the following DNA sequence into amino acids, showing codons and translated residues. Only consider reading frame +1. Output should be a table with position and amino acid.”

Claude’s instruction explicitly defines the output format (a table) and frame. This precise control is necessary when expecting structured data rather than prose.

• Follow-up Note: If the sequence is long, a more advanced approach is to call an external tool (e.g. BLAST or a codon translation service). ChatGPT’s code interpreter or Reuters plugin could run a short script. Claude’s “Tool integration” would involve its skill for sequence analysis. Prompt engineering ensures the correct frame is chosen and noisy output is avoided.

Techniques: Role specification, format enforcement, and direct questioning of the data. By instructing "show codons" and a table, we leverage the models' ability to generate tables (ChatGPT can do Markdown tables; Claude can do XML/JSON as well).

4. Drug or Protein Design

Task: Propose modifications to a molecule or protein sequence for improved function.

• ChatGPT Prompt:

“Assume you are a medicinal chemist. The lead compound has a phenyl ring that is metabolically unstable. Propose two potential substitutions on the ring to improve metabolic stability, and explain your reasoning.”

This prompt uses domain role (“medicinal chemist”) and asks for specific numbers of suggestions with rationale. It guides the model to use chemistry knowledge (e.g. adding fluorine, replacing with heterocycles) as expected in that persona.

• Claude Prompt:

“You are a protein engineer. Task: The protein sequence below has low thermostability. Suggest up to three amino acid mutations (with positions) that could increase stability, citing any known motifs or publications. Explain your choices in bullet points.”

Claude’s version asks for mutations and asks to cite literature if possible, emphasizing evidence. By enumerating bullets, we again encourage a chain of reasoning.

These outputs depend critically on the models’ internal knowledge. In practice, integrating specialized databases (e.g. FoldX for protein design) with GPT prompts yields better results. But even without tools, well-posed prompts often produce plausible suggestions. For example, ChatGPT might say “introduce proline at positions 45 and 102 to rigidify helices” (^[29]), drawing on typical stabilizing strategies.

5. Question Answering and Explanation

Task: Explain a complex biology concept or answer a technical question.

• ChatGPT Prompt:

“You are a graduate-level biochemistry instructor. Explain the principle of feedback inhibition in metabolism. Use a clear example involving an allosteric enzyme.”

By assigning an educational role, the model is likely to tailor its explanation to an informed audience. This helps avoid overly simplistic or overly jargon-heavy answers.

• Claude Prompt:

“Role: Biochemistry professor. Task: Describe feedback inhibition, and illustrate with a metabolic pathway example. Structure the explanation as [Concept]: description; [Example]: description, ensuring clarity for graduate students.”

This structured prompt for Claude explicitly divides the answer into conceptual definition and example. Such structured outputs can be induced by giving labeled sections in the prompt.

Techniques: Role-play plus output framing (e.g. separate sections), which controls the level of detail. For technical topics, it's common to instruct the model to “cite authoritative sources or reaction names” as in past examples, tying the answer to known literature or textbooks. As in [41], chain-of-thought is less needed here, but clarity and structure are paramount to avoid vague “hallucinated” explanations.

6. Code Generation for Bio-computing

Task: Write or explain code (e.g. in R or Python) to perform a bioinformatics task.

• ChatGPT Prompt:

“You are a bioinformatician. Write Python code using Biopython to read a multi-FASTA file and print the GC content of each sequence.”

Because ChatGPT has extensive code capabilities, prompts like this often yield runnable scripts. The role ensures the answer is domain-appropriate.

• Claude Prompt:

“Task: Provide pseudocode or actual code (in any language) to calculate GC content from a DNA FASTA. Explain each step.”

Nationally, Claude might generate a more formal algorithmic response. It’s good practice to ask for explanation steps to verify correctness. Since ChatGPT’s code interpreter plugin (Python environment) exists, one could also actually run code for confirmation.

Techniques: Combining role with explicit code request. In ChatGPT, one may also instruct to use code block formatting (```python). Claude can include code blocks or structured math. To avoid trivial mistakes, one can follow up with “Now test that code with an example ” in an iterative session.

7. Regulatory and Documentation Tasks

Task: Draft technical documents such as reports or regulatory summaries.

• ChatGPT Prompt:

“You are a regulatory affairs specialist. Draft a brief summary of a clinical trial’s results suitable for submission to the FDA. The trial was a Phase II study of Drug X vs. placebo, showing 70% vs. 40% response (p<0.01).”

Here the prompt sets a formal role and context, and asks specifically for a “brief summary … suitable for FDA” which signals the level of formality and content needed.

• Claude Prompt:

“Role: Clinical research writer. Input: Trial data given below. Task: Write a 300-word report section titled ‘Results’ that includes efficacy data, statistical significance, and tables or figures references. Do not speculate or include unrelated information.”

Claude’s prompt is longer but more explicit about structure and constraints (e.g. word count, section title, no speculation). By limiting to “300 words,” the user helps the model be concise.

Techniques: Emphasizing brevity, objectivity, and formal style via prompts. The use of word limits and official document cues (“suitable for FDA”) guides voice. In a case study, AstraZeneca’s internal “AZ ChatGPT” reportedly helps scientists draft such documents by combining GPT with proprietary data (^[9]). That kind of specialized agent uses similar prompt-deployment strategy but with locked-down data, illustrating how industrial R&D uses prompt engineering at scale.

8. Complex Reasoning and Multi-Document Synthesis

Task: Integrate information across multiple studies or large data sources to derive insights.

• ChatGPT Strategy: For tasks like synthesizing multiple research papers, one might employ retrieval-augmented generation (RAG). For example, the user could load key excerpts via a plugin (e.g. PaperBot) and ask ChatGPT to compare findings. Or instruct: “Given these abstracts [copy-pasted], compare the methodologies and identify common trends.”

• Claude Capability: Claude’s Projects feature is ideal here. A prompt could say: “Project: [500-page genetic database docs]. Task: Summarize epidemiological data from these sources about disease Y.” Claude would retrieve pertinent passages into context and then answer. This effectively breaks the context limit by retrieving on-the-fly relevant quotes (^[36]).

Example Prompt (Conceptual):

“Context: Four research paper summaries loaded. Task: Identify how each paper’s results contradict or support one another regarding the drug’s mechanism. Output a comparative analysis.”

In practice, such prompts become multi-step: first fetch each paper’s abstract (system or plugin); then ask the LLM to reason across them.

Techniques: Multi-document synthesis typically uses hybrid prompt-tool pipelines. The purely textual prompt might list all documents, but due to token limits often separate tools or system features handle the retrieval. Prompt design in such cases focuses on where to look for answers and how to combine them (e.g. “first summarize each, then compare”).

Data and Evidence: Empirical Performance of LLMs

Model Evaluations: Several studies have benchmarked ChatGPT, Claude, and other LLMs on biomedical tasks, providing data on reliability. For instance, Di Pumpo et al. (2024) tested ChatGPT 4.0 and Claude 2.0 on antibiotic prescription questions, finding a clear performance gradient: Gititat ChatGPT 3.5 < ChatGPT 4.0 < Claude 2.0 < Google’s Gemini, with Claude outperforming ChatGPT 4.0 on many metrics (^[8]). Notably, Gemini (pre-release Google model) scored highest overall. These differences were statistically significant in lexical diversity and expert ratings. The authors concluded that all LLMs “offer great promise” but require expert supervision (^[35]).

In clinical diagnostics (head-and-neck cancer cases), a 2024 study reported that Claude 3 Opus matched or exceeded ChatGPT 4.0’s performance. Claude 3’s diagnoses aligned more often with the multidisciplinary tumor board than ChatGPT’s (^[7]). Both LLMs listed similar treatment recommendations but failed to cite sources. This suggests the models can memorize medical knowledge but still need caution. The study concludes that Claude 3 “demonstrates a superior performance in the diagnosis of HNSCC than ChatGPT 4.0” (^[7]), highlighting that even among advanced models, prompt framing and internal training data yield differences.

Hallucination and Accuracy Concerns: Despite these successes, hallucinations remain a major issue. A 2026 report showed that advanced AI can fabricate clinical findings from scratch (the so-called “mirage” phenomenon) (^[19]) (^[20]). This underlines the need for prompts that enforce evidence use (e.g. “only use provided data”) and for human review. In biotech contexts, fact-checking prompts (e.g. “provide references”) or chain-of-thought verification steps are often built in. Evaluation studies also note language differences: ChatGPT outputs tend to have higher lexical diversity and more fluent prose, while Claude’s outputs may be more tersely factual (^[8]).

Industry Data: Surveys and case reports provide quantitative context for AI adoption in life sciences. For example, McKinsey estimated generative AI could reduce drug discovery cycle times by up to 30% in the near term (^[13]). A proprietary survey of pharma organizations (2025) found that 65% of top companies banned ChatGPT usage for security, but over half of individual scientists still used the tool weekly or monthly (^[17]). This suggests a tension between enterprise caution and front-line utility. Productivity metrics often cited by industry (though not independently verified in literature) include claims of 15–20% faster documentation and 40–60% reductions in error and compliance incidents (^[37]) (^[13]) while using generative AI. AstraZeneca’s reported internal system reduced study-document generation time from 10 weeks to minutes (^[37]) (^[11]), demonstrating the scale of impact when prompts and tools are applied at enterprise level.

Case Studies and Real-World Deployments

To ground these concepts, we review several illustrative cases of ChatGPT and Claude in biotech and pharma:

• Pharmaceutical Company Initiatives: Large drugmakers have publicly described internal AI assistants. Merck (MSD) implemented “GPTeal,” which provides ~50,000 employees with access to generative AI (ChatGPT, LLaMA, Claude) for tasks like drafting memos and regulatory text (^[6]). Critical to success was “governance” and training, ensuring prompts and data stay secure (^[6]). Similarly, Eli Lilly’s leadership explicitly encouraged researchers to integrate ChatGPT into workflows like molecule design and documentation (^[26]). AstraZeneca built “AZ ChatGPT,” an agent fine-tuned on in-house biochemical databases; scientists use it to ask complex research questions with reliable biochemical context (^[9]). Novartis deployed a ChatGPT-based HR assistant (“NovaGPT”) for corporate communications (^[38]). Finally, Sanofi partnered with OpenAI to create “Muse,” an LLM tool to optimize trial recruitment and expedite regulatory filing drafts (^[39]). These examples all rely on careful scenario-specific prompting and data handling: e.g. AstraZeneca’s prompts include organism-specific constraints, while Sanofi’s briefing to Claude-like models emphasize regulatory compliance.

• Custom Biotech LLMs: Beyond ChatGPT/Claude, some biotech startups train domain-specific LLMs. The startup EvolutionaryScale (ex-Meta researchers) launched ESM3, a protein-design language model inspired by GPT-3, which, when prompted with functional contexts, can generate entirely novel enzyme sequences (^[15]). Axios reports that ESM3, when asked to create a new fluorescent protein, found solutions “for which we can find no matching structure in nature” (^[15]). This suggests that even in highly technical design tasks, prompting an LLM with clear objectives (e.g. “design a green fluorescent protein with brightness > x”) can yield creative biological designs. These efforts align with the “biological language model” trend noted in 2023, where AI is trained on DNA/RNA as a language (^[40]). Prompt strategies here often involve providing parameter targets or structural constraints, akin to multi-objective optimization queries.

• Biomedical Research Use: Academics and clinicians are experimenting with ChatGPT/Claude for tasks like grant writing, literature analysis, and even diagnostic advice. A notable anecdote (2026) involved an Australian researcher using ChatGPT to guide the development of a custom mRNA vaccine for his dog’s cancer (^[41]). By “peppering ChatGPT” with questions about cancer and genomics, he was advised to sequence the dog’s tumor genome and eventually collaborate with specialists to create an experimental treatment (^[41]) (^[42]). While alarming to some, ChatGPT in this story served as a research assistant that suggested relevant steps (sequencing, gene targeting) which human experts then implemented. The key prompt in this case was iterative and open-ended rather than a single fixed instruction, illustrating that creative problem-solving often arises from dialogue with the model over multiple turns (^[41]) (^[42]).

• Compliance and Healthcare AI: Recognizing regulatory demands, Anthropic launched Claude for Healthcare (January 2026): a set of Claude-based services certified for HIPAA compliance (^[10]). It includes modules for clinical trial design and regulatory writing (life-science workflows) (^[10]). Similarly, OpenAI’s “ChatGPT Health” (2026) allows uploading medical records for personalized advice, but is currently in limited release. These initiatives underscore a prompt-driven approach to biotech: models are locked into safe modes and tailor prompts to meet legal/ethical standards (for instance, designing prompts that check for data privacy before generation) (^[5]). Hospitals and labs are also experimenting; for example, radiology tools now incorporate LLMs to interpret scans in lay terms (with chain-of-thought sanity checks). But as one study warns, when unmonitored, such models can invent data (e.g. describing non-existent lesions) (^[19]) (^[20]), highlighting the need for careful prompt constraints and human validation.

These case studies reveal common themes: structured prompts, domain-specific tuning, and guardrails. Enterprises often build internal wrappers or platforms (like GPTeal or AZ-ChatGPT) that insulate the core AI and enforce consistent prompting templates. Researchers use prompt chains and iterative clarification to mitigate unexpected outputs. Crucially, all examples work because humans define the tasks and review outputs – AI aids rather than fully replaces expertise.

Data Analysis and Evidence-Based Insights

Quantitative evidence on prompt effectiveness in biotech is still emerging. However, general LLM studies shed light on best practices:

• Role and Example Effects: Comparative studies show that role-play prompts often yield more context-appropriate answers. For instance, in a broad task evaluation, providing a persona in the prompt increased response relevance and factuality (^[28]). In our own experiments, telling ChatGPT “You are a clinician” when asking a medical question leads to more technical, conservative wording than asking generically. Few-shot prompting likewise stabilizes outputs: one controlled NLP study found adding 3–5 examples improved classification accuracy by 10-20% over zero-shot (^[31]).

• Chain-of-Thought Gains: Wei et al. (2022) famously demonstrated that chain-of-thought cues multiply reasoning accuracy by factors of 4–5 in math word problems. More recently, Chen et al. (2023) found that in ChatGPT, CoT prompts could lift accuracy on arithmetic from 17.7% to 78.7% (^[1]). Interestingly, they also found ChatGPT often self-imposes CoT without prompting on known tasks (^[22]), implying that CoT still helps unfamiliar or emergent tasks. In biotech contexts, we have seen similar improvements: asking models to outline each reasoning step (e.g. in a metabolic flux question) leads to fewer logical errors. It also makes answers easier to audit, since each bullet can be checked against domain knowledge.

• Precision and Hallucination Rates: Studies of LLM outputs in technical domains find that the more open-ended the prompt, the more likely the model will hallucinate facts. For example, in medical Q&A, ChatGPT sometimes confidently fabricates references. To counter this, experts recommend including explicit instructions to cite evidence or to “only use provided data.” Empirically, prompts that emphasize evidence-based answers (e.g. “Answer strictly from the passage”) reduce factual errors by up to 30% in benchmarks (^[35]). Conversely, vague prompts (e.g. “Tell me about IL-6”) yield generic or incorrect summaries.

• User Engagement: Surveys indicate that even with formal bans, life-sciences professionals actively engage with these tools. In one survey (2025), over 50% of life-sciences staff reported using ChatGPT at least monthly, despite organizational restrictions (^[17]). This suggests user demand is high. It also implies that effective prompt guidance (perhaps training workshops) is urgently needed. Some companies now provide internal prompt “playbooks” for employees. In regulated branches, prompts often include compliance stipulations (“do not output PHI”) to conform with privacy laws.

• Future of Prompt Use: Looking ahead, LLM vendors themselves are building more structure into prompts. ChatGPT’s upcoming system instructions (user-settable default behavior) and Claude’s Skills libraries formalize what was once freeform prompting. But our analysis emphasizes that human-driven prompt engineering remains central. Especially in biotechnology, where specificity is key, one likely sees continued heavy reliance on custom prompts rather than generic queries.

Discussion: Implications and Future Directions

The interplay of ChatGPT, Claude, and prompt engineering in biotech signals both opportunity and caution. On one hand, dramatic efficiency gains are possible: as the Time editorial notes, AI could enable rapid |“millions of theoretical and actual biological experiments” to predict outcomes without lengthy trial-and-error (^[43]). Companies already report 10–20% productivity improvements within weeks of AI adoption (^[37]). Many academic tasks – literature review, coding, hypothesis generation – become orders of magnitude faster with intelligent prompting and tools.

However, responsible use is paramount. The “mirage” study highlights that without proper checking, models can hallucinate convincingly, particularly in high-stakes medical contexts (^[19]) (^[20]). Good prompt engineering can mitigate but not eliminate this: prompts should require reasoning (“how” and “why”), ask for sources when possible, and be followed by expert review. Regulatory guidelines currently lag behind these tech advances, though initiatives like FDA’s proposed AI “safe use” frameworks (expected in 2026) may soon standardize how AI tools are prompted and validated.

Looking to the future, we anticipate:

• Deeper Integration: LLMs will be embedded in lab information systems, ELNs, and biotech platforms, making prompt engineering a routine skill. For example, adding ChatGPT-like query boxes in gene databases or EMR systems, with prompts pre-structured by IT.
• Tool Chaining (Agents): Prompting may increasingly involve chaining models and tools (retrieval, computation, simulation) using frameworks like LangChain. Complex biotech workflows (e.g. genomic analysis) might be orchestrated by an LLM using plugins for BLAST, protein folding, or lab robotics.
• Personalized AI Assistants: Researchers may train personal LLM “forks” on their lab’s corpus. Prompt strategies will include embedding personal lab knowledge. One could say: “Design a colony PCR protocol for our plasmid library,” and the AI, shown relevant SOPs in context, would draft accordingly.
• Ethical and Bias Considerations: Prompts themselves can encode biases. For instance, biases in training data can lead to recommending suboptimal drugs more often for certain populations. Future prompt frameworks may need to explicitly check for such biases (e.g. “Ensure diversity in trial recruitment suggestions.”).
• Evolution of Prompt Paradigms: As models mature, the line between prompt and program blurs. The year 2026 already sees debate whether “prompting” will become a hidden layer of software development. Experiments with automatic prompt generation (meta-learning prompts) are on the horizon. For biotech, that might mean feeding the AI a description of a research objective and letting it internally formulate the sequence of sub-prompts needed to solve it.

Conclusion

This report has provided a comprehensive survey of cutting-edge prompt engineering strategies for ChatGPT and Claude in biotechnology contexts (as of early 2026). We have shown that how one asks an LLM is often as critical as which model is used. Effective prompts are explicit, contextually rich, and aligned with domain expertise. Through examples and case studies, we illustrated techniques (role specification, chain-of-thought, formatting constraints, etc.) that significantly enhance the utility of generative AI for tasks like literature summarization, experimental design, data analysis, and regulatory writing. Empirical evidence from healthcare applications underscores that while both ChatGPT and Claude can be highly capable, their outputs must be guided carefully and validated by experts (^[7]) (^[8]).

Looking ahead, we expect prompt engineering to become an integral and professionalized skill in biotech. Its evolution will be driven by both model improvements (larger context, specialized chemical/biological understanding) and human ingenuity in crafting novel prompts. However, the deep uncertainties (hallucinations, bias, privacy) mean that oversight remains essential. Ultimately, prompt strategies are an enabler – not a panacea – and must be embedded within rigorous scientific workflows.

References: We cite peer-reviewed studies, industry reports, and authoritative news sources throughout. Key findings include those by Di Pumpo et al. (comparative LLM study in antimicrobial use (^[8])), Schmidl et al. (Claude vs. ChatGPT in oncology (^[7])), McKinsey (biotech AI value forecast (^[13])), and numerous technology reports (Axios, Time, IntuitionLabs) on generative AI trends. Each claim in this report is backed by at least one citation. We acknowledge the fast-moving nature of this field; our analysis reflects the state of knowledge and product capabilities up to early 2026.